The evidence is pharmacokinetic and practice-based, not controlled outcome evidence
In the trials, individuals with diabetes lost less weight with these medications than those without diabetes
Other GLP-1 subcutaneous injections like Ozempic and Mounjaro, approved for type 2 diabetes, are also used off-label for weight loss
Conservative dosing (1mg daily) At 1mg per day, 100mg provides exactly 100 doses
animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists

Also, those who have anemia or are vegetarian or vegan will want to consider a B12 regimen, as vegetable-based diets generally dont contain the amount of B12 that you need to thrive